Yeon Hee Park

home / authors / yeon-hee-park

Articles

11 Phase 3 Study of Neoadjuvant Pembrolizumab or Placebo Plus Chemotherapy, Followed by Adjuvant Pembrolizumab or Placebo Plus Endocrine Therapy for Early-Stage High-Risk ER+/HER2– Breast Cancer: KEYNOTE-756

11 Phase 3 Study of Neoadjuvant Pembrolizumab or Placebo Plus Chemotherapy, Followed by Adjuvant Pembrolizumab or Placebo Plus Endocrine Therapy for Early-Stage High-Risk ER+/HER2– Breast Cancer: KEYNOTE-756

Fatima Cardoso;Joyce O’Shaughnessy, MD;Heather McArthur, MD, MPH;Peter Schmid, MD;Javier Cortés, MD;Nadia Harbeck, MD, PhD;Melinda L. Telli, MD;David W. Cescon;Peter A. Fasching;Zhimin Shao;Delphine Loirat;Yeon Hee Park;Manuel Gonzalez Fernandez;Gábor Rubovszky;Seock-Ah Im;Rina Hui;Toshimi Takano;Fabrice André;Hiroyuki Yasojima;Zhenzhen Liu;Yu Ding;Liyi Jia;Vassiliki Karantza;Konstantinos Tryfonidis;Aditya Bardia, MD, MPH
August 18th 2024
32 Neoadjuvant Pembrolizumab or Placebo Plus Chemotherapy Followed by Adjuvant Pembrolizumab or Placebo for Early-Stage Triple- Negative Breast Cancer: Updated Event-Free Survival Results From the Phase 3 KEYNOTE-522 Study

32 Neoadjuvant Pembrolizumab or Placebo Plus Chemotherapy Followed by Adjuvant Pembrolizumab or Placebo for Early-Stage Triple- Negative Breast Cancer: Updated Event-Free Survival Results From the Phase 3 KEYNOTE-522 Study

Peter Schmid, MD;Javier Cortes;Rebecca Dent, MD;Lajos Pusztai, MD, DPhil;Heather McArthur, MD, MPH;Sherko Kümmel;Carsten Denkert;Yeon Hee Park;Rina Hui;Nadia Harbeck, MD, PhD;Masato Takahashi;Theodoros Foukakis;Marie-Ange Mouret-Reynier;Marta Ferreira;Seock-Ah Im;Fatima Cardoso;Yu Ding;Wilbur Pan;Konstantinos Tryfonidis;Joyce O’Shaughnessy, MD
July 7th 2024

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
3 KOLs are featured in this series.
Published: September 23rd 2024 | Updated: October 18th 2024
Advanced HCC: Key Takeaways
A 71-Year-Old Male Presents for Evaluation of Painless Bump on His Chin
Published: May 27th 2011 | Updated: October 18th 2024
A 71-Year-Old Male Presents for Evaluation of Painless Bump on His Chin
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: October 18th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes